fda approvals in follicular lymphoma and prostate cancer, biosimilar is granted approval, and more
Published 6 years ago • 143 plays • Length 9:41
Download video MP4
Download video MP3
Similar videos
-
7:39
fda approvals in follicular lymphoma and gi, lung nets, snda in prostate cancer, and more
-
13:36
fda approval in prostate cancer, nda submitted in cll and follicular lymphoma, and more
-
9:29
fda approvals in all and breast cancer, priority reviews in cml and follicular lymphoma, and more
-
8:51
fda approvals in nets, breast cancer, aml, a biosimilar, and more
-
7:26
fda approval in ovarian cancer, priority reviews in nsclc, cll, and follicular lymphoma, and more
-
10:49
fda approvals in melanoma and breast cancer, and priority reviews in prostate cancer and more
-
9:25
fda approvals in large b-cell lymphoma and melanoma, priority reviews in cscc and nsclc, and more
-
9:17
fda approvals in cscc, nsclc, and myeloma, breakthrough designation in prostate cancer, and more
-
10:18
fda approvals in bladder cancer and hodgkin lymphoma, breakthrough designation in aml, and more
-
13:02
fda approvals in non-hodgkin lymphoma, breast cancer, gvhd, and mesothelioma
-
1:16
dr. leonard on the fda approval of tazemetostat in follicular lymphoma
-
10:01
fda approvals in sclc and a biosimilar, and japanese approvals in aml, ntrk tumors, and more
-
9:41
asco's cancer advance of the year, fda approval in nets, and more
-
8:58
john p. leonard, md, on the fda approval of tazemetostat for follicular lymphoma
-
1:16
dr. lacasce discusses the fda approval of lenalidomide/rituximab in non-hodgkin lymphoma
-
14:39
new fda approved parp inhibitor: talzenna (talazoparib) & xtandi | #markscholzmd #alexscholz #pcri
-
5:12
follicular lymphoma: overview of treatment options
-
1:25
targeted therapy for the treatment of follicular lymphoma
-
0:57
dr. skarbnik on the approval of tazemetostat in relapsed/refractory follicular lymphoma
Clip.africa.com - Privacy-policy